Clark Capital Management Group, Inc.
Position in NBIX — Neurocrine Biosciences Inc
CIK 1352187
PHILADELPHIA, PA
Position in NBIX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$15,630,062
New position
Shares Held
92,738
first reported quarter
Ownership
0.091%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#124
of 768 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Clark Capital Management Group, Inc. holds $17,087,306 across 3 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (91.5% of the industry book) .
All Filings in NBIX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,630,062 | 92,738 | Shares | Sole | 2026-08-11 | |
| No filing history on record for this holder in this stock. | ||||||